NEJM: Anticoagulants Help Moderately Ill COVID-19 Patients
UT Southwestern Medical CenterModerately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center.